依帕列净是格列沙星类药物，在2014的成人中被批准用于治疗2型糖尿病。
(3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-one
(S)-3-(4-(2-Chloro-5-iodobenzyl)phenoxy)tetrahydrofuran
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
(2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone
(2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
(S)-(2-Chloro-5-iodophenyl)(4-((tetrahydrofuran-3-yl)oxy)phenyl)methanone
2-Chloro-5-iodobenzoic acid
5-Bromo-2-chlorobenzoic acid
4-(5-Bromo-2-chlorobenzyl)phenol
5-Bromo-2-chlorobenzaldehyde
(R)-Tetrahydrofuran-3-yl 4-methylbenzenesulfonate
(S)-(+)-3-Hydroxytetrahydrofuran
2,3,4,6-Tetra-O-(trimethylsilyl)-D-glucono-delta-lactone
(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-hydroxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
(5-Bromo-2-chlorophenyl)(4-methoxyphenyl)methanone
4-Bromo-1-chloro-2-(4-methoxybenzyl)benzene
